AVIEW LCS vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by RapidAI

AI Verdict

AVIEW LCS is designed for comprehensive lung cancer screening and cardiopulmonary assessment, including nodule analysis, emphysema, and coronary artery calcification. Rapid RV/LV, conversely, specializes in the rapid AI-powered assessment of pulmonary embolism severity by measuring right and left ventricle ratios from CTPA scans. While both are radiology AI tools for cardiopulmonary imaging, their distinct primary clinical applications make them suitable for different diagnostic needs.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is a comprehensive, AI-powered solution for lung cancer screening and integrated cardiopulmonary assessment from a single low-dose CT scan. This tool is ideal for programs requiring automated lung nodule detection, detailed quantification, and long-term follow-up comparisons, alongside concurrent assessment of COPD and coronary artery calcification.

View AVIEW LCS →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your priority is the rapid, AI-driven assessment of pulmonary embolism severity, particularly in acute care or emergency settings. This tool excels at quickly measuring right and left ventricle ratios from CTPA scans to aid in timely clinical decision-making and patient triage for suspected PE.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS Rapid RV/LV
Pricing Subscription or one-off payment Contact vendor for pricing information.
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Unknown
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW LCS

AVIEW LCS offers a wider range of deployment options, including cloud, hybrid, and various local virtualization methods (VM, Docker), which provides greater flexibility for integration into diverse IT infrastructures. It also emphasizes automated report generation and streamlining radiology workflows, contributing to a more adaptable and efficient user experience.

Clinical Value

AVIEW LCS

AVIEW LCS provides a comprehensive, multi-disease assessment from a single low-dose CT scan, covering lung cancer screening, COPD, and coronary artery calcification. This integrated approach offers broader clinical utility by identifying multiple critical conditions, enhancing diagnostic accuracy, and potentially impacting preventative care more significantly than a single-purpose tool.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information. Without transparent pricing details or publicly available cost-effectiveness studies for either product, it is not possible to determine which offers better value.

Enterprise Readiness

AVIEW LCS

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating a strong foundation for enterprise use. However, AVIEW LCS provides more extensive deployment flexibility, including full cloud-based and various local virtualization options, which can better accommodate diverse enterprise IT strategies and scalability needs.

Innovation

AVIEW LCS

While both leverage AI for automated analysis, AVIEW LCS stands out with its integrated, multi-disease assessment from a single low-dose CT scan, simultaneously analyzing lung cancer, COPD, and coronary artery calcification. This comprehensive approach represents a significant innovation in integrated diagnostic workflows and preventative health.

Support & Docs

Tie

Both Coreline Soft and RapidAI are established companies in the healthcare AI sector and are expected to provide standard commercial support. While RapidAI explicitly mentions 24/7/365 support via email and phone and a 'Customer Success' team, Coreline Soft also lists a 'Customer Service Team' with contact details. Without more granular comparative details on SLAs, dedicated portals, or training programs, it is difficult to definitively distinguish between their support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS Rapid RV/LV
Product Name AVIEW LCS Rapid RV/LV
Company Coreline Soft Co. RapidAI (formerly iSchemaView)
Primary Focus/Use Case AI-powered solution for the detection and analysis of lung nodules, COPD, and coronary artery calcification from a single low-dose CT scan. AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Key AI Capabilities Automated lung nodule detection and analysis, Lung-RADS classification, Nodule volume quantification, Emphysema quantification, Coronary Artery Calcification (CAC) scoring, Automated comparison of nodules in follow-up CT scans. AI-powered analysis of CTPA images, Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio, Annotated images showing ventricular measurements.
Specialties Cardiology, Oncology, Pulmonology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Rapid RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, providing integrated analysis for lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. Rapid RV/LV is an FDA-cleared AI tool specifically for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
AVIEW LCS offers automated lung nodule detection and analysis, Lung-RADS classification and reporting, nodule volume quantification and 3D segmentation, emphysema quantification (LAA index), and coronary artery calcification (CAC) scoring. Rapid RV/LV provides automated measurement of right and left ventricle diameters and calculates the RV/LV ratio, along with annotated images showing these ventricular measurements.
AVIEW LCS performs its analysis from a single low-dose CT scan, which can be non-enhanced and non-gated. Rapid RV/LV specifically analyzes CTPA (CT Pulmonary Angiography) images to assess pulmonary embolism severity.
AVIEW LCS is designed for integration with PACS/RIS and third-party platforms, and can generate comprehensive, automated reports. Rapid RV/LV integrates with the broader Rapid PE solution and offers triage and notification capabilities as part of that platform.
AVIEW LCS provides a comprehensive, integrated analysis for lung cancer screening, COPD, and coronary artery calcification from a single low-dose CT scan, covering multiple cardiopulmonary conditions. Rapid RV/LV is focused specifically on the rapid assessment of pulmonary embolism severity.
AI Tool Finder
AI-powered search. Results may not be comprehensive.